Andrea Landorph

Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy

Elena Holm, Thomas C. Abshire, Joel Bowen et al. · Blood Coagulation & Fibrinolysis · 2015 · 58 citations

Medicine, Hematology, Clinical Epidemiology +14

Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)

Nicola Curry, Canan Albayrak, Miguel A. Escobar et al. · Haemophilia · 2019 · 36 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2

Paul Giangrande, Faraizah Abdul Karim, László Nemes et al. · Journal of Thrombosis and Haemostasis · 2020 · 28 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Long‐term safety and efficacy of N8‐GP in previously treated pediatric patients with hemophilia A: Final results from pathfinder5

Sonata Šaulytė Trakymienė, Marina Economou, Gili Kenet et al. · Journal of Thrombosis and Haemostasis · 2020 · 25 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

<p>Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII</p>

Susan Kearney, Leslie Raffini, Tan Phat Pham et al. · Patient Preference and Adherence · 2019 · 23 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +8